Biotech Start-up Insurance UK
Biotech start-up insurance covers early-stage life sciences companies as they move from research towards products, often after spinning out of a university or setting up in an incubator. The core covers are property and equipment, deterioration of stock for samples and cell lines, employers' and public liability, professional indemnity, cyber, and directors' and officers' liability, which investors usually ask for. As the company starts human studies or supplies products, it will also need clinical trials and products liability cover. Insurers want to know what the science is, what stage the company has reached, what hazardous materials are handled and where the work takes place. Getting the programme right early avoids problems at funding rounds and with landlords.
Key facts at a glance
- Investors expect D&O. Directors' and officers' cover is usually a condition of funding.
- Incubators set minimum cover. Lab space licences often specify liability limits.
- Spin-outs need their own policies. University insurance usually stops when the company leaves.
- Clinical trials change everything. Human studies need dedicated cover before the first participant.
- IP and data are key assets. Cyber and data protection matter from day one.
What insurance does a biotech start-up need?
Cover depends on your stage. Most start-ups begin with a core package and add covers as they grow.
| Stage | Typical covers |
|---|---|
| Early research | Equipment, stock, employers' and public liability, cyber |
| First funding round | Directors' and officers', professional indemnity |
| Own lab space | Property, deterioration of stock, business interruption |
| Pre-clinical work | Wider liability and contract requirements |
| Clinical trials | Clinical trials insurance for each study |
| Commercial supply | Products liability and product recall |
For a wider view of lab cover, see our laboratory insurance page.
Leaving university insurance
Spin-outs are often covered by the university's insurance while they share its space. That usually stops when the company becomes independent or moves to its own lab.
Plan the switch before the move. Check what the licence agreement for any incubator or science park requires, what the university expects you to hold, and whether any work done under the university's cover carries on. Gaps often appear around equipment transferred from the university and samples created before the spin-out.
Science park and incubator licences often ask for £5 million or £10 million public liability and to be named on the policy. Check before you sign.
Why does D&O matter to biotech investors?
Directors' and officers' insurance protects the board against claims about how the company is run. Investors usually want it in place before they take a board seat.
In biotech, D&O claims can arise from failed trials, funding disputes, regulatory investigations or shareholder disagreements. Investor-appointed directors will want to know the limit and the wording before they join the board. It is one of the first things to arrange when a funding round is on the horizon.
What do insurers ask a biotech start-up?
- The science and the products in development
- Stage of development and timeline to clinical trials
- Hazardous materials, organisms and containment levels
- Equipment values and sample storage
- Location, incubator or science park
- Funding position and investor requirements
- Collaborations and contracts with partners
Frequently asked questions
Usually employers' and public liability, equipment and stock cover, and cyber.
Usually before the first institutional funding round.
Only while the arrangement lasts. Check when it ends.
Yes, before any human study starts.
Yes, including specialist instruments.
Deterioration of stock cover can protect them.
Most do, often with minimum liability limits.
If you provide research services or advice to others, yes.
Yes. We review and extend cover as you reach new stages.
Usually within a week for early-stage companies.
Related guides from Miller & Partner
Miller & Partner Limited (FRN 1029698) is an Appointed Representative of Gauntlet Risk Management Ltd (FRN 308081), which is authorised and regulated by the Financial Conduct Authority. Miller & Partner Limited is registered in England and Wales (company number 16206282) and trades from Vivian House, Roman Bridge Close, Mumbles, Swansea SA3 5BG. This article is general information, not a personal recommendation or an offer of cover. Cover is subject to insurer acceptance and the full terms, conditions and exclusions of the policy issued.
Instagram
LinkedIn